If you need more lookups,
subscriptions start at $34 USD/month.
Shouvik Roy Location
West Chester, PA, US
Shouvik Roy Work
Executive Director, Head of Mixed Modalities, Sterile Product Development @ (August 2024 - Present)
Senior Director, CMC Program Leadership, Biologics @ (June 2020 - August 2024)
Director, CMC Leader, Innovative Programs, Biologics R and D @ (February 2018 - May 2020)
Associate Director, Head of Drug Product Operations, Biologics R and D @ (March 2015 - January 2018)
Principal Scientist, Drug Product and Process Development @ (March 2012 - January 2015)
Senior Scientist and Group Leader, Drug Product and Process Development @ (June 2009 - March 2012)
Scientist, Drug Product and Process Development @ (February 2006 - June 2009)
Shouvik Roy Education
University of Colorado Anschutz
Ph.D (Pharmaceutical Biotechnology)
2002-2005
The University of Toledo
M.S (Industrial Pharmacy/ Pharmaceutics)
2000-2002
Jadavpur University
B.S (Pharmacy)
1996-2000
Shouvik Roy Skills
Biotechnology
Biopharmaceuticals
Formulation
Technology Transfer
GMP
Pharmaceutical Industry
CAPA
Life Sciences
Protein Chemistry
FDA
Validation
Process Simulation
Drug Discovery
Commercialization
Corrective and Preventive Action (CAPA)
Operations
Strategic Planning
Drug Product
Leadership
Support
Product Support
Flexible Manufacturing
Biologics
SQL
Microsoft Excel
Corrective and Preventive Action Capa
Management
Corrective and Preventive Action
Shouvik Roy Summary
Shouvik Roy, based in West Chester, PA, US, is currently a Executive Director, Head of Mixed Modalities, Sterile Product Development at Merck. Shouvik Roy brings experience from previous roles at Teva Pharmaceuticals and Amgen. Shouvik Roy holds a 2002 - 2005 Ph.D in Pharmaceutical Biotechnology @ University of Colorado Anschutz. With a robust skill set that includes Biotechnology, Biopharmaceuticals, Formulation, Technology Transfer, GMP and more. Shouvik Roy has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Shouvik Roy?
Find contact details for 700 million professionals.